Global Pharmaceuticals & Biotech Most Popular Stocks

Amneal Pharmaceuticals

Market Cap: US$3.0b

A global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products worldwide.

Virbac

Market Cap: €2.6b

Manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, and the Pacific.

Beijing Aosaikang Pharmaceutical

Market Cap: CN¥21.6b

Beijing Aosaikang Pharmaceutical Co., Ltd.

Mineralys Therapeutics

Market Cap: US$3.0b

A clinical-stage biopharmaceutical company, develops medicines to target diseases driven by dysregulated aldosterone in the United States.

NewAmsterdam Pharma

Market Cap: US$3.0b

A late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with metabolic disease.

Viking Therapeutics

Market Cap: US$3.0b

A clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders.

J. B. Chemicals & Pharmaceuticals

Market Cap: ₹261.5b

Manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally.

Perrigo

Market Cap: US$2.9b

Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

Procaps Group

Market Cap: US$2.9b

Develops, produces, and markets pharmaceutical solutions in South America, Central America, North America, and Europe.

Piramal Pharma

Market Cap: ₹259.2b

Operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally.

Inner Mongolia Furui Medical Science

Market Cap: CN¥20.7b

Inner Mongolia Furui Medical Science Co., Ltd.

Apellis Pharmaceuticals

Market Cap: US$2.9b

A commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs.

Kolon TissueGene

Market Cap: ₩4.1t

Develops cell therapies for orthopedic diseases and other unmet medical needs.

Mabwell (Shanghai) Bioscience

Market Cap: CN¥20.5b

A biopharmaceutical company, engages in the research and development, manufacture, and commercialization of biological products for oncology, immunology, bone disorders, ophthalmology, hematology, and infectious diseases in China and internationally.

Hybio Pharmaceutical

Market Cap: CN¥20.4b

Engages in the development, manufacture, and commercialization of therapeutic peptides API and peptide-based drugs in China and internationally.

Syngene International

Market Cap: ₹253.5b

A contract research and manufacturing company, provides drug discovery and development services in India, the United States of America, Europe, and internationally.

Indivior

Market Cap: US$2.9b

Develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.

Jamjoom Pharmaceuticals Factory

Market Cap: ر.س10.6b

Manufactures and markets pharmaceutical products in the Kingdom of Saudi Arabia and internationally.

Emcure Pharmaceuticals

Market Cap: ₹251.3b

Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.

Almirall

Market Cap: €2.4b

Operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa.

Xenon Pharmaceuticals

Market Cap: US$2.8b

A neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders in Canada.

Bavarian Nordic

Market Cap: DKK 17.9b

Develops, manufactures, and supplies life-saving vaccines.

CG Oncology

Market Cap: US$2.8b

A late-stage clinical biopharmaceutical company, develops and commercializes backbone bladder-sparing therapeutics for patients with bladder cancer.

Ultragenyx Pharmaceutical

Market Cap: US$2.8b

A biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific.

Bora Pharmaceuticals

Market Cap: NT$84.2b

Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.

Shandong Buchang Pharmaceuticals

Market Cap: CN¥19.6b

Shandong Buchang Pharmaceuticals Co., Ltd.

BioArctic

Market Cap: SEK 25.8b

Develops biological drugs for patients with central nervous system disorders in Sweden.

Hypera

Market Cap: R$14.6b

Operates as a pharmaceutical company in Brazil.

Fujian Cosunter Pharmaceutical

Market Cap: CN¥19.4b

Engages in the research and development, manufacture, and sale of pharmaceutical products in China.

China Resources Double-Crane PharmaceuticalLtd

Market Cap: CN¥19.3b

China Resources Double-Crane Pharmaceutical Co.,Ltd.

InventisBio

Market Cap: CN¥19.3b

A clinical stage biotech company, engages in the discovery and development of therapeutics for cancer and metabolic diseases in China and the United States.

Organon

Market Cap: US$2.7b

Develops and delivers health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, Latin America, the Middle East, Russia, Africa, and internationally.

Wockhardt

Market Cap: ₹239.9b

Operates as a pharmaceutical and biotech company, in India, the United States, the United Kingdom, Switzerland, Ireland, Russia, Europe, and internationally.

Immunovant

Market Cap: US$2.7b

A clinical-stage immunology company, develops monoclonal antibodies for the treatment of autoimmune diseases.

SK bioscienceLtd

Market Cap: ₩3.8t

Engages in the research and development, production, and distribution of vaccines and biopharmaceuticals in Korea and internationally.

HUTCHMED (China)

Market Cap: UK£2.0b

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.